Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma

Lian, Christine Guo, Xu, Yufei, Ceol, Craig, Wu, Feizhen, Larson, Allison, Dresser, Karen, Xu, Wenqi, Tan, Li +23 more·2012·Cell
DOI 10.1016/j.cell.2012.07.033

Cited by (811)

Items 801–811 of 811

  1. Tumor cell-intrinsic TET3 restrains type I interferon signaling and anti-tumor immunity
    L Liu, Wenxuan Zhao, Tianbao Shang, BH Xu, Mengyuan Wang, Xinze Li, Jie Min, Wenqi Xu, Hongjie Shen, Li Tan et al. · 2026 · Science China Life Sciences
  2. GSDME acts as an epigenetic modifier to promote melanoma development via centriole biogenesis regulator PLK4
    Juan Du, Yuqi Yang, Mao Zhao, Haitao Zhang, Xia Li, Di Qu, Jianzhang Wang, Xiangxu Wang, Xiuli Yi, J X Ma et al. · 2026 · Cell Death and Differentiation
  3. Oncogenic BRAF and KRAS Promote Global DNA Hypomethylation Through a Directed Pathway That Upregulates TET3
    Ichiro Onoyama, W. Rod Hardy, Shoichiro Takeishi, Lihua Julie Zhu, Yanglan Tan, Lloyd Hutchinson, Jianhong Ou, Leyuan Ma, Ching-Man A. Virbasius, Masafumi Yasunaga et al. · 2026 · Cancer Science
  4. Decoding nucleic acid modification regulatory networks: A key to cancer intervention and treatment
    Qi Sun, Yunxuan Shi, Yadong Guo, Xiaojing Wang, Fu Zhao, Ziwei Zhang, Aimin Jiang, Zengkan Du, Zhijie Zhao · 2026 · Physics of Life Reviews
  5. Increased TET3 expression associates with proinflammatory cytokines and reduced 5-hydroxymethylcytosine in periapical lesions
    Martín Pacheco, Camila Rodríguez, Mauricio Baeza, Benjamín Morales, María José Bordagaray, Marcelo Britos, Alejandra Fernández V, Marcela Hernández · 2026 · Clinical Oral Investigations
  6. Urinary DNA Methylation and Hydroxymethylation Dynamics as Candidate Biomarkers of Occupational Chemical Exposure—An Exploratory Pilot Study
    Andrzej Radosław Reindl, Kamil Pająk, Mateusz Podlasiewski, Alicja Maria Dębska-Ślizień, Alicja Trawińska, Tomasz Ksiazek, Agnieszka Siomek, Fabian Leśniewski, Rafał Różalski · 2026 · International Journal of Molecular Sciences
  7. TET2 downregulation limits oxidative stress-induced cytotoxicity of high dose ascorbate in dabrafenib-resistant melanoma cells
    Eleicy Nathaly Mendoza, Serena Castelli, Angela De Cristofaro, Enrico Desideri, Grazia Graziani, Pedro Miguel Lacal, Maria Rosa Ciriolo, Fabio Ciccarone · 2026 · Cancer Drug Resistance
  8. Molecular Diagnosis of Melanocytic Neoplasia: Updates and Challenges
    Jaclyn M. Plotzke, Grace Wang, Scott C. Bresler, Paul W. Harms · 2026 · Cancers
  9. Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions
    Yixuan Ren, Lei Yang, Boyi Fei, Rong Guo, Junran Huang, Zhenghao Xu, Ruoran Wang, Pinqi Zhang, Dandan Cao, Pan Chen et al. · 2026 · Science China Life Sciences
  10. BindingDB Entry 50007356: Cytosine-Based TET Enzyme Inhibitors.
    BindingDB · 2021 · UC San Diego
  11. Emerging Anti-cancer Targets in Mitochondria
    Petr Ježek, Katarína Smolková, Aleš Dvořák, Tomáš Olejár · 2014 · Springer eBooks